I dette kliniske forsøg randomiseredes 255 patienter til behandling med docetaxel (75 mg/ m² som en 1 - times intravenøs infusion hver 3. uge) og capecitabin (1250 mg/ m2 to gange daglig i 2 uger efterfulgt af en uges pause).
In this trial, 255 patients were randomised to treatment with docetaxel (75 mg/ m2 as a 1 hour intravenous infusion every 3 weeks) and capecitabine (1250 mg/ m2 twice daily for 2 weeks followed by 1-week rest period).